Polypid logo

Polypid Share Price Today

(NASDAQ: PYPD)

Polypid share price is $2.93 & ₹254.82 as on 6 Mar 2025, 2.30 'hrs' IST

$2.93

0.02

(0.52%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Polypid share price in Dollar and Rupees. Guide to invest in Polypid stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Polypid, along with analyst recommendations, forecasts, and comprehensive financials.

Polypid share price movements

  • Today's Low: $2.82
    Today's High: $2.95

    Day's Volatility :4.53%

  • 52 Weeks Low: $2.37
    52 Weeks High: $5.92

    52 Weeks Volatility :59.97%

Polypid (PYPD) Returns

PeriodPolypid LtdIndex (Russel 2000)
3 Months
-1.19%
0.0%
6 Months
-15.26%
0.0%
1 Year
-48.77%
0.0%
3 Years
-97.94%
-11.6%

Polypid (PYPD) Key Statistics

in dollars & INR

Previous Close
$2.9149
Open
$2.9144
Today's High
$2.9539
Today's Low
$2.82
Market Capitalization
$30.2M
Today's Volume
$2.5K
52 Week High
$5.92
52 Week Low
$2.37
Revenue TTM
$0.0
EBITDA
$-26.2M
Earnings Per Share (EPS)
$-5.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1038.73%

How to invest in Polypid Stock (PYPD) from India?

It is very easy for Indian residents to invest directly in Polypid from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Polypid stock in both Indian Rupees (INR) and US Dollars (USD). Search for Polypid or PYPD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Polypid or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Polypid shares which would translate to 0.297 fractional shares of Polypid as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Polypid, in just a few clicks!

Returns in Polypid (PYPD) for Indian investors in Rupees

The Polypid stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Polypid investment value today

Current value as on today

₹56,457

Returns

₹43,543

(-43.54%)

Returns from Polypid Stock

₹48,506 (-48.51%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Polypid (PYPD)

-63%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Polypid Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Polypid

  • Rosalind Advisors, Inc.

    9.99%

  • AIGH Capital Management, LLC

    8.12%

  • Dafna Capital Management LLC

    2.86%

  • J. Goldman & Co LP

    1.26%

  • Stonepine Capital Management Llc

    1.02%

  • ADAR1 Capital Management LLC

    0.79%

Analyst Recommendation on Polypid

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Polypid(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Polypid Stock (PYPD)

What analysts predicted

Upside of 275.43%

Target:

$11.00

Current:

$2.93

Insights on Polypid Stock (Ticker Symbol: PYPD)

  • Price Movement

    In the last 3 years, PYPD stock has moved down by -98.0%
  • PYPD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 108.4%
  • PYPD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 145.7%

Polypid Technicals Summary

Sell

Neutral

Buy

Polypid is currently in a neutral trading position according to technical analysis indicators.

Polypid (PYPD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Polypid Ltd logo
-1.52%
-15.26%
-48.77%
-97.94%
-99.49%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Polypid Ltd logo
NA
NA
NA
-1.71
-10.39
-0.86
NA
0.75
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Polypid Ltd logo
Buy
$30.2M
-99.49%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Polypid

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. The company has research and development collaboration with ImmunoGenesis, Inc. to enhance cancer immunotherapy using PLEX technology. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Organization
Polypid
Employees
0
CEO
Ms. Dikla Czaczkes Akselbrad
Industry
Health Technology

Management People of Polypid

NameTitle
Ms. Dikla Czaczkes Akselbrad
CEO & Director
Mr. Jonny Missulawin
Chief Financial Officer
Ms. Dalit Hazan
Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs
Mr. Ori Warshavsky
Chief Operating Officer - US
Ms. Maria Rubin
Executive Vice President of Operations
Mr. Tal Vilnai
General Counsel & Corporate Secretary
Ms. Rivi Lev-ari
Vice President of Human Resource
Dr. Jean-Marc Hagai Pharm.D.
Chief Commercial Officer

Important FAQs about investing in PYPD Stock from India :

What is Polypid share price today?

Polypid share price today stands at $2.93, Open: $2.91 ; Previous Close: $2.91 ; High: $2.95 ; Low: $2.82 ; 52 Week High: $5.92 ; 52 Week Low: $2.37.

The stock opens at $2.91, after a previous close of $2.91. The stock reached a daily high of $2.95 and a low of $2.82, with a 52-week high of $5.92 and a 52-week low of $2.37.

Can Indians buy Polypid shares?

Yes, Indians can invest in the Polypid (PYPD) from India.

With INDmoney, you can buy Polypid at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Polypid at zero transaction cost.

How can I buy Polypid shares from India?

It is very easy to buy Polypid from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Polypid (PYPD) be purchased?

Yes, you can buy fractional shares of Polypid with INDmoney app.

What are the documents required to start investing in Polypid stocks?

To start investing in Polypid, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Polypid Stock (PYPD)?

Today’s highest price of Polypid (PYPD) is $2.95.

Today’s lowest price of Polypid (PYPD) is $2.82.

What is today's market capitalisation of Polypid?

Today's market capitalisation of Polypid PYPD is 30.2M

What is the 52 Week High and Low Range of Polypid Stock (PYPD)?

  • 52 Week High

    $5.92

  • 52 Week Low

    $2.37

What are the historical returns of Polypid (PYPD)?

  • 1 Month Returns

    -1.52%

  • 3 Months Returns

    -15.26%

  • 1 Year Returns

    -48.77%

  • 5 Years Returns

    -99.49%

Who is the Chief Executive Officer (CEO) of Polypid ?

Ms. Dikla Czaczkes Akselbrad is the current Chief Executive Officer (CEO) of Polypid.